
BiotechTV - News ASGCT 2025: Capsida Biotherapeutics is using its expertise in capsid design to develop gene therapies that are tissue specific, and in the case of the CNS, can be delivered via IV and crosses the BBB
May 14, 2025
Chapters
Transcript
Episode notes
